Defibrillators

Diluted earnings per share were 15 cents, compared with 11 cents, the company said.

Meanwhile, Zoll unveiled a new model of the Zoll AutoPulse Non-Invasive Cardiac Support Pump, which, the company said, can document, store, and upload device and patient data.

In a statement, Zoll chief executive Richard A.

Packer said the company may benefit in the coming months from problems at a rival, Medtronic Inc.

of Minnesota.

"With the suspension of shipments by Medtronic's Physio Control division, our largest competitor, during the quarter, we are faced with a number of opportunities," he said.

(By Chris Reidy, Globe staff) Posted by Boston Globe Business Team at 08:17 AM Print rss © The New York Times Company ...

It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes a wider area of the chest in a consistent, uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest.* Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions.

About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation.

With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims.

ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries.

The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin Americ...

Strong results in these areas more than offset a low level of military business in the quarter." Commenting further, Mr.

Packer stated, "We are excited to have shipped the first units of the R Series, our new hospital product, this quarter.

The early customer response to the product has been strong.

Our positioning of the R Series as "Simple, Smart and Ready" is resonating with customers.

Clearly, our second quarter North America hospital results do not yet reflect the opportunity presented by this product and our International launch is being executed just this month.

Therefore, we look forward to increased momentum with this new platform as we move through the balance of the year." Highlighting progress with the AutoPulse, Mr.

Packer noted, "Shipment growth in the second quarter continued at a strong rate of 36%, reflecting significant growth in the International market generally and our first shipments to Japan.

Our distribution partner in Japan, Nihon Kohden, is very excited about the potential for the AutoPulse in their market and we expect sales to ramp throughout the year.

However, sales in the US EMS market were somewhat less than we expected and we need to work to keep our sales force focused on the very large opportunity represented by the AutoPulse." With res...